Trial Profile
Phase IIb trial of ICA 105665 in patients with chronic, treatment-refractory epilepsy.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2009
Price :
$35
*
At a glance
- Drugs ICA 105665 (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Sponsors Neusentis
- 29 Sep 2009 New trial record.